From ASPHALION, we would like to inform you of the opening of the call:
HORIZON-HLTH-2021-DISEASE-04-04: Clinical validation of artificial intelligence (AI) solutions for treatment and care
This topic aims at supporting activities under the Horizon EU call “Tackling diseases and reducing disease burden”. Proposals, based on existing (pre)clinical evidence, should focus on implementing clinical studies to validate AI-based solutions as clinical decision tools comparing their benefits versus standard-of-care treatments in non-communicable diseases.
ASPHALION, as SME company, is actively involved in more than 12 EU granted projects as regulatory expert partners.
Whether you are planning to apply and you would like to add a regulatory partner to the project, or if you are interested in knowing more about ASPHALION and our European granted projects expertise, do not hesitate to contact us at:
